Development of CTCL-Seq, a Rapid, High Throughput Method to Simultaneously Assay All Known Oncogenes and Tumor Suppressors in Cutaneous T Cell Lymphoma

Project: Research project

Description

We are developing a rapid, high throughput genetic test to simultaneously assess all known oncogenes and tumor suppressors in Cutaneous T Cell Lymphoma. This test will be useful for diagnosis and staging of patients and should pave the way for tailoring therapeutic strategies for each patient based on molecular data.
StatusFinished
Effective start/end date3/1/166/28/17

Funding

  • Skin Cancer Foundation (Agreement 1/5/16)

Fingerprint

Cutaneous T-Cell Lymphoma
Oncogenes
Neoplasms
Therapeutics